- Home
- ORMP vs OXLCP Comparison
ORMP vs OXLCP Comparison
Compare ORMP & OXLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- OXLCP
- Stock Information
- Founded
- ORMP 2002
- OXLCP N/A
- Country
- ORMP United States
- OXLCP United States
- Employees
- ORMP N/A
- OXLCP N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- OXLCP Investment Managers
- Sector
- ORMP Health Care
- OXLCP Finance
- Exchange
- ORMP Nasdaq
- OXLCP Nasdaq
- Market Cap
- ORMP 93.9M
- OXLCP N/A
- IPO Year
- ORMP N/A
- OXLCP N/A
- Fundamental
- Price
- ORMP $2.27
- OXLCP $24.37
- Analyst Decision
- ORMP
- OXLCP
- Analyst Count
- ORMP 0
- OXLCP 0
- Target Price
- ORMP N/A
- OXLCP N/A
- AVG Volume (30 Days)
- ORMP 91.7K
- OXLCP N/A
- Earning Date
- ORMP 11-06-2025
- OXLCP N/A
- Dividend Yield
- ORMP N/A
- OXLCP N/A
- EPS Growth
- ORMP N/A
- OXLCP N/A
- EPS
- ORMP N/A
- OXLCP N/A
- Revenue
- ORMP $2,000,000.00
- OXLCP N/A
- Revenue This Year
- ORMP N/A
- OXLCP N/A
- Revenue Next Year
- ORMP N/A
- OXLCP N/A
- P/E Ratio
- ORMP N/A
- OXLCP N/A
- Revenue Growth
- ORMP N/A
- OXLCP N/A
- 52 Week Low
- ORMP $1.82
- OXLCP N/A
- 52 Week High
- ORMP $3.09
- OXLCP N/A
- Technical
- Relative Strength Index (RSI)
- ORMP 54.03
- OXLCP 46.51
- Support Level
- ORMP $2.17
- OXLCP $24.10
- Resistance Level
- ORMP $2.45
- OXLCP $24.48
- Average True Range (ATR)
- ORMP 0.06
- OXLCP 0.12
- MACD
- ORMP 0.01
- OXLCP -0.01
- Stochastic Oscillator
- ORMP 43.75
- OXLCP 31.03
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About OXLCP Oxford Lane Capital Corp.
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.